{
    "nct_id": "NCT03467789",
    "official_title": "Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma in Basal Cell Nevus Syndrome",
    "inclusion_criteria": "* Diagnosis of Basal Cell Nevus Syndrome (BCNS) as defined in the Consensus Statement from the first International colloquium on BCNS.\n\n  * Major Criteria are:\n\n    * (1) BCC prior to age 20 years, or excessive number of BCCs out of proportion to prior sun exposure and skin type;\n    * (2) keratocyst of the jaw prior to age 20;\n    * (3) palmar or plantar pitting;\n    * (4) lamellar calcification of the falx cerebri;\n    * (5) medulloblastoma;\n    * (6) first degree relative with BCNS;\n    * (7) Patched-1 (PTCH1) gene mutation.\n  * Minor Criteria are:\n\n    * (1) rib anomalies, or other specific skeletal malformations including kyphoscoliosis and short 4th metacarpals;\n    * (2) macrocephaly;\n    * (3) cleft/lip or palate;\n    * (4) fibroma of the heart or ovary;\n    * (5) ocular abnormalities;\n  * For diagnosis of BCNS, the participant must have either 2 major criteria, one major and two minor criteria.\n* At least three BCC tumors, two of which are biopsy-proven\n* Female subjects must not become pregnant during the study\n* Subjects must be able to understand and willing to sign a written informed consent document\nHealthy volunteers allowed",
    "exclusion_criteria": "* Pregnant or nursing.\n* At risk for hypercalcemia (renal disease, sarcoidosis, etc.)\n* Taking vismodegib or a hedgehog pathway inhibitor; must stop at least 3 months prior to visit 1.\n* Taking any topical treatment on their BCC tumors; must stop at least 1 month prior.\n* Taking Vitamin D or multivitamin supplements; must stop at least 1 month prior.\n* Currently undergoing treatment for other cancers with medical or radiation therapy.\n* Participants with a known hypersensitivity to 5-aminolevulinic acid or any component of the study material.\n* Participants with history of a photosensitivity disease, such as porphyria cutanea tarda.\n* Currently participating in another clinical trial.",
    "miscellaneous_criteria": ""
}